Can't sign in? Forgot your username?
Enter your email address below and we will send you your username
The frequency with which invasive fungal infections (IFIs) occur has markedly increased over the past decade. The ability to rapidly detect and identify the causative fungal agents is essential for…1
The ability to detect fungi in clinical material depends on several factors, including the quality of the specimen that is received into the laboratory. If very small samples are received,…1
Detection of antibodies targeting fungal pathogens may be useful in a range of IFIs, particularly when they occur in immunocompetent patients; however, these assays may have limited use in significantly…2
The main antigen used as a diagnostic marker in commercially available kits for IA is galactomannan (GM), a carbohydrate molecule with a mannose backbone. GM is released from the cell…12
(1,3)‐β‐d‐Glucan (BDG) is an integral polysaccharide cell wall component present in the fungal cell wall of most pathogenic fungi, with the notable exception of Cryptococcus, the…15
Many fungal metabolites, as well as antigens, have been evaluated for their utility in detecting fungi in clinical specimens. Metabolites that have been assessed include d‐arabinitol…16
Nucleic acid detection for diagnosis of fungal infections and identification of the etiological agent has been actively pursued since the early 1990s. Theoretically, this method offers many advantages, including the…16
Volume Editor: Bobbi S. Pritt
Editors in Chief: Karen C. Carroll and Michael A. Pfaller
Copyright © 2023 by ASM Press. ASM Press is a registered trademark of the American Society for Microbiology. All rights reserved. No part of this publication may be reproduced or transmitted in whole or in part or reutilized in any form or by any means, electronic or mechanical, including photocopying and recording, or by any information storage and retrieval system, without permission in writing from the publisher.